REGISTER TODAY

Dexcom Wear & Learn
Hands-On Training


Experience offered at
ADCES 2026



Gain direct experience and practical insights through real-world application.

Register for a complimentary educational trial designed to give participants a unique opportunity to experience Stelo by Dexcom from the user perspective.

During this guided session (approximately 20 minutes), participants will:
  • Explore the app onboarding process
  • Independently apply a sensor with support from a Dexcom Clinical Education Specialist
  • Experience real-time, personalized glucose insights within the app
Participants will leave with a sensor applied and a better understanding of how to explore personalized glucose insights using the Stelo app.

Eligibility Requirements:

Participants must
  • Be a licensed healthcare professional—prescribing or non-prescribing—or a healthcare student
  • Be a resident of the United States
  • Be an adult 18 years or older not on insulin
  • Be unfamiliar with Stelo and need further education
  • Have a compatible smartphone*
Important Information & Restrictions
  • Registration is required. Participation is first come, first served.
  • Participants will receive only one sensor to be self-applied during the session.
  • Individuals who have previously participated in a Dexcom hands-on training or sampled the product are not eligible to trial the same product again. Note: If you have not yet experienced the reimagined Stelo app launched this summer, you remain eligible.
  • Prescribers practicing in Vermont are not eligible to participate.
  • Industry participants and exhibiting staff are not eligible to participate.
  • Stelo is currently available only in the United States. Users must have a United States based Google/Apple account to download the Stelo app.
REGISTER TODAY
NEW!
Introducing a reimaged Stelo experience. Released this summer, Stelo’s app enhancements include new features that simplify glucose tracking and provide insights into how daily factors impact glycemic patterns, supporting behavior change. Click here to learn more about the suite of new features.

 

WHEN

August 7-9, 2026

WHERE

ADCES 2026 | Halls A & B | BS 1000

Get to know
the Dexcom portfolio

PRODUCT HIGHLIGHT

Dexcom G7 15 Day

Prescribe G7 15 Day for adult patients 18+ with:†

  • Type 1 or type 2 diabetes, regardless of insulin use1
  • Diabetes during pregnancy1
  • AID (automated insulin delivery) system
  • Most-covered CGM for all types of diabetes‡,2
  • Available at pharmacies and DME suppliers

Learn more about Dexcom G7 15 DAy
Side image
PRODUCT HIGHLIGHT

Stelo by Dexcom

Recommend Stelo for adult patients aged 18+ with: †,3

  • Prediabetes
  • An interest in tracking their glucose for health insights
  • Type 2 diabetes not on insulin who do not have insurance coverage for CGM
  • No prescription needed

LEARN MORE ABOUT STELO BY DEXCOM
Side image
This program is not part of ADCES 2026. This event is neither sponsored nor endorsed by Associate of Diabetes Care and Education Specialists. This event does not qualify for continuing medical education (CME) credit.

* For Stelo app compatibility information, visit stelo.com/compatibility.
† For adults 18 years and older.
‡ Individual pricing may vary depending on commercial insurance coverage

1 Dexcom G7 15 Day User Guide. 2 Data on file (VV-06805). Dexcom; 2025. 3 Stelo User Guide.

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

© 2026 Dexcom, Inc. All rights reserved.
MAT-13798